» Articles » PMID: 2886992

Transforming Growth Factor Type Beta Induces Monocyte Chemotaxis and Growth Factor Production

Overview
Specialty Science
Date 1987 Aug 1
PMID 2886992
Citations 313
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have focused on the potential role of transforming growth factor type beta (TGF-beta) as an immunoregulatory peptide. In this context, we demonstrate that TGF-beta is a potent chemoattractant for human peripheral blood monocytes. At concentrations from 0.1 to 10 pg/ml, TGF-beta induces directed monocyte migration in vitro. Consistent with this observation is the expression of high-affinity TGF-beta receptors on the monocytes with a Kd of 1-10 pM. At higher concentrations of TGF-beta (greater than or equal to 1 ng/ml), monocytes are stimulated to generate biologically active mediator(s) that enhance fibroblast growth. Gene expression for one of these growth factors, interleukin 1, is induced in monocytes within hours after exposure to TGF-beta. Thus, TGF-beta may provide an important signal for monocyte recruitment and for regulation of their synthesis of mediators of fibroblast growth and activity in wound healing.

Citing Articles

Human intraepithelial mast cell differentiation and effector function are directed by TGF-β signaling.

Derakhshan T, Hollers E, Perniss A, Ryan T, McGill A, Hacker J J Clin Invest. 2025; 135(1).

PMID: 39744949 PMC: 11684804. DOI: 10.1172/JCI174981.


Unraveling the complex interplay of sex, endocrinology, and inflammation in post-Injury articular cartilage breakdown through in silico modeling.

Hutcherson C, Luke B, Khader K, Dhaher Y Sci Rep. 2024; 14(1):28654.

PMID: 39562596 PMC: 11576913. DOI: 10.1038/s41598-024-77730-x.


Combined effect of pantoprazole and mesenchymal stem cells on experimentally induced gastric ulcer: implication of oxidative stress, inflammation and apoptosis pathways.

Sayed A, Mahmoud N, Mohawed O, Ahmed H Inflammopharmacology. 2024; 32(3):1961-1982.

PMID: 38652367 PMC: 11136780. DOI: 10.1007/s10787-024-01469-0.


TGF-β signaling in health, disease, and therapeutics.

Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C Signal Transduct Target Ther. 2024; 9(1):61.

PMID: 38514615 PMC: 10958066. DOI: 10.1038/s41392-024-01764-w.


The TGF-β superfamily as potential therapeutic targets in pancreatic cancer.

Tindall R, Bailey-Lundberg J, Cao Y, Ko T Front Oncol. 2024; 14:1362247.

PMID: 38500662 PMC: 10944957. DOI: 10.3389/fonc.2024.1362247.


References
1.
Zigmond S, Hirsch J . Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973; 137(2):387-410. PMC: 2139498. DOI: 10.1084/jem.137.2.387. View

2.
Ohura K, Katona I, Wahl L, Chenoweth D, Wahl S . Co-expression of chemotactic ligand receptors on human peripheral blood monocytes. J Immunol. 1987; 138(8):2633-9. View

3.
Wahl S, Wahl L, McCarthy J . Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol. 1978; 121(3):942-6. View

4.
Schmidt J, Mizel S, Cohen D, Green I . Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol. 1982; 128(5):2177-82. View

5.
Deuel T, Senior R, Huang J, Griffin G . Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest. 1982; 69(4):1046-9. PMC: 370161. DOI: 10.1172/jci110509. View